Q3 Earnings Estimate for CME Group Issued By Zacks Research

CME Group Inc. (NASDAQ:CME) – Zacks Research boosted their Q3 2026 earnings estimates for shares of CME Group in a research note issued to investors on Thursday, January 8th. Zacks Research analyst Team now forecasts that the financial services provider will post earnings of $2.82 per share for the quarter, up from their prior forecast of $2.81. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s FY2026 earnings at $11.62 EPS, Q3 2027 earnings at $3.45 EPS and FY2027 earnings at $12.43 EPS.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the business posted $2.68 earnings per share. The firm’s revenue was down 3.0% on a year-over-year basis.

Other equities research analysts also recently issued research reports about the stock. The Goldman Sachs Group reduced their target price on shares of CME Group from $264.00 to $263.00 and set a “sell” rating on the stock in a research note on Thursday, December 4th. Barclays upped their price target on shares of CME Group from $280.00 to $304.00 and gave the company an “equal weight” rating in a report on Friday, December 12th. Royal Bank Of Canada raised their price objective on shares of CME Group from $282.00 to $295.00 and gave the stock a “sector perform” rating in a research note on Friday, December 5th. Argus dropped their target price on CME Group from $308.00 to $295.00 in a research report on Friday, October 31st. Finally, UBS Group reiterated a “neutral” rating on shares of CME Group in a report on Tuesday, January 6th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $291.06.

CME Group Price Performance

NASDAQ:CME opened at $264.98 on Monday. The firm has a market capitalization of $95.55 billion, a price-to-earnings ratio of 25.68, a PEG ratio of 3.39 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The business has a 50 day simple moving average of $273.96 and a 200-day simple moving average of $271.83. CME Group has a 1 year low of $225.46 and a 1 year high of $290.79.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were issued a $1.25 dividend. The ex-dividend date was Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s payout ratio is presently 48.45%.

Insider Activity at CME Group

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the transaction, the director owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. This represents a 47.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares in the company, valued at approximately $17,737,468.20. This represents a 27.53% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in CME. National Wealth Management Group LLC bought a new stake in CME Group during the fourth quarter valued at about $266,000. Sax Wealth Advisors LLC lifted its position in shares of CME Group by 2.6% during the fourth quarter. Sax Wealth Advisors LLC now owns 2,491 shares of the financial services provider’s stock valued at $680,000 after buying an additional 62 shares during the last quarter. Czech National Bank boosted its holdings in shares of CME Group by 3.9% in the 4th quarter. Czech National Bank now owns 95,083 shares of the financial services provider’s stock valued at $25,965,000 after buying an additional 3,554 shares in the last quarter. First Bank & Trust bought a new stake in shares of CME Group in the 4th quarter valued at about $1,325,000. Finally, Salvus Wealth Management LLC grew its position in shares of CME Group by 5.1% in the 4th quarter. Salvus Wealth Management LLC now owns 933 shares of the financial services provider’s stock worth $255,000 after buying an additional 45 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.